TheEdgeResearch
Home / Stocks / EHOS

Ehouse Global, Inc. (EHOS)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$10,127
Sector
Healthcare
Industry
Biotechnology
Beta
-6.88
52-Wk Range
0.000001-0.00001
CEO
Jonathan Smith
Country
US
Currency
USD

Ehouse Global, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $10,127. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -6.88 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-0.52
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.38
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2013-07-03
Headquarters
San Diego, CA, US
About Ehouse Global, Inc.

Ehouse Global, Inc. specializes in the formulation, production, and distribution of liquid nutritional supplements. The company's diverse product portfolio features a variety of liquid offerings, including essential vitamins, minerals, athletic performance enhancers, dietary support solutions, and general well-being products. Co-founded in 2003 by Scott Corlett and Edward J. Peplinski, the firm's corporate headquarters are located in San Diego, California.

Comparable companies

Ehouse Global, Inc. is most often compared with the following Healthcare names:

BBBTBRAXFGBLXGSTCHTDSIRBSMOBONVOSPBLASONX
More research on EHOS
EHOS technical analysis EHOS TheEdge Score Compare against peers
Open full interactive analysis & DCF →